Claret Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.63M Buy
186,359
+13,374
+8% +$619K 1.12% 23
2025
Q1
$10.6M Sell
172,985
-1,638
-0.9% -$99.9K 1.52% 16
2024
Q4
$9.88M Buy
174,623
+2,199
+1% +$124K 1.56% 15
2024
Q3
$8.92M Sell
172,424
-655
-0.4% -$33.9K 1.46% 17
2024
Q2
$7.19M Buy
173,079
+5,832
+3% +$242K 1.28% 19
2024
Q1
$9.07M Buy
167,247
+21,183
+15% +$1.15M 1.52% 16
2023
Q4
$7.5M Buy
146,064
+11,839
+9% +$607K 1.34% 18
2023
Q3
$7.79M Buy
134,225
+1,323
+1% +$76.8K 1.53% 17
2023
Q2
$8.5M Buy
132,902
+9,417
+8% +$602K 1.66% 18
2023
Q1
$8.56M Buy
123,485
+28,258
+30% +$1.96M 1.69% 19
2022
Q4
$6.85M Sell
95,227
-387
-0.4% -$27.8K 1.51% 20
2022
Q3
$6.8M Buy
95,614
+207
+0.2% +$14.7K 1.61% 20
2022
Q2
$7.35M Buy
95,407
+1,728
+2% +$133K 1.58% 20
2022
Q1
$6.84M Buy
93,679
+20,175
+27% +$1.47M 1.32% 22
2021
Q4
$4.58M Buy
73,504
+32,825
+81% +$2.05M 0.85% 30
2021
Q3
$2.41M Buy
40,679
+8,178
+25% +$484K 0.41% 45
2021
Q2
$2.17M Buy
32,501
+11,880
+58% +$794K 0.36% 46
2021
Q1
$1.3M Hold
20,621
0.24% 57
2020
Q4
$1.28M Sell
20,621
-144
-0.7% -$8.93K 0.25% 59
2020
Q3
$1.25M Sell
20,765
-64
-0.3% -$3.86K 0.28% 62
2020
Q2
$1.23M Buy
20,829
+445
+2% +$26.2K 0.29% 64
2020
Q1
$1.14M Buy
20,384
+9
+0% +$502 0.32% 60
2019
Q4
$1.31M Buy
20,375
+1,214
+6% +$77.9K 0.25% 68
2019
Q3
$972K Buy
19,161
+2,128
+12% +$108K 0.2% 79
2019
Q2
$772K Buy
17,033
+417
+3% +$18.9K 0.16% 86
2019
Q1
$793K Hold
16,616
0.16% 88
2018
Q4
$864K Sell
16,616
-32
-0.2% -$1.66K 0.19% 84
2018
Q3
$1.03M Buy
16,648
+651
+4% +$40.4K 0.2% 80
2018
Q2
$885K Sell
15,997
-85
-0.5% -$4.7K 0.18% 85
2018
Q1
$1.02M Hold
16,082
0.23% 76
2017
Q4
$986K Buy
+16,082
New +$986K 0.22% 84